CRVS
Corvus Pharmaceuticals, Inc.Company with tickers: CRVS
CIK
1626971
CUSIP
221015100
Shares Outstanding
84,090,424
13F Activity (30d)
149 filings
149 filers
Price
$12.83
Market Cap
$1.08B
P/E Ratio
-24.21
EPS (Diluted)
$-0.53
52W High
$26.95
52W Low
$3.38
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $14,877,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $11,175,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-14,877,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-13,692,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.15 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.15 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |